To prevent the cholinesterase enzyme from hydrolyzing the neurotransmitters, several cholinesterase inhibitors such as donepezil, rivastigimine, tacrine, ensaculin, and galantamine have been designed, and used for the treatment of cognitive dysfunction and memory loss of AD patients. This evidence concerns the gene BCHE and Alzheimer disease.